The Publication Database hosted by SPL
|
The Evolution of Multiple Sclerosis Lesions on Serial MR
|
|
Institution: |
Department of Radiology, Brigham and Women's Hospital, Boston, MA 02115, USA. |
Publisher: |
AJNR Am J Neuroradiol |
Publication Date: |
Aug-1995 |
Volume Number: |
16 |
Issue Number: |
7 |
Pages: |
1481-1491 |
Citation: |
AJNR Am J Neuroradiol. 1995 Aug;16(7):1481-91. |
PubMed ID: |
7484637 |
Appears in Collections: |
SPL, CNI, NCIGT |
Sponsors: |
N01-NS-0-2397 (NS) funded by NINDS |
Generated Citation: |
Guttmann C.R.G., Ahn S.S., Hsu L., Kikinis R., Jolesz F.A. The Evolution of Multiple Sclerosis Lesions on Serial MR. AJNR Am J Neuroradiol. 1995 Aug;16(7):1481-91. PMID: 7484637. |
| Downloaded: | 1160 times. [view map] |
| Paper: | Download, View online |
| Export citation: |
To characterize temporal changes in signal intensity patterns of multiple sclerosis lesions on serial MR. METHODS: T1-, T2-, proton density-, and contrast-enhanced T1-weighted MR was performed on five patients with relapsing-remitting multiple sclerosis at least 22 times in the course of 1 year. RESULTS: Forty-three enhancing lesions and 1 new lesion that never showed enhancement were detected and followed for periods ranging from approximately 4 weeks to 1 year (total of 702 time points). At first detection the center of new lesions was brighter than the periphery (20 of 24 new lesions on proton density-weighted and 19 of 23 new lesions on contrast-enhanced images). On contrast-enhanced images, ring hyperintensity was predominant at time points later than 29 days. As lesions aged, a residual rim of "nonenhancing" hyperintensity often was noted on contrast-enhanced images. Some older lesions (> 1 year) showed similar appearance on unenhanced T1-weighted images. On proton density-weighted images ring hyperintensity was most frequent 2 to 4 months after lesion detection. The estimated average duration of gadopentetate dimeglumine enhancement was 1 to 2 months. CONCLUSIONS: A lesion evolution pattern relevant to MR was inferred. We believe that specific information about the histopathologic evolution of a lesion may be extracted not only from contrast-enhanced but also from nonenhanced serial MR. Assessment of drugs targeting specific phases of lesion evolution could benefit from quantitative pattern analysis of routine MR images.
Additional Material
1 File (381.956kB)
Guttmann-AJNR1995-fig6.jpg (381.956kB)
